China on the Move: Fine-Tuning the Life Sciences Regulatory

In China, recent technological advances and legislative and regulatory developments that attempt to balance risk mitigation and innovation continue to reshape the life sciences sector in terms of cross-border partnerships and domestic business operations.

Related Keywords

China , Guangdong , Jilin , Macau , Hong Kong , Chinese , , Biotechnology Development , Administration Of Drug Production , Guidance For International Collaboration , No International Collaboration Approvals Filings , Sole Foreign Party , China Ministry Of Science , International Collaboration Approvals Filings Section , China National Center , China National Medical Products Administration , No Separate Approval For International Collaboration , International Collaboration Approval Filing , Drug Development Activities , International Collaboration Approvals Filings , National Medical Products Administration , Outsourcing Approach Involving Provincial , Drug Production , Drug Production Measures , Key Personnel , Quality Management System , Practices Related , Contract Manufacturing , Biological Products , Multi Component Biochemical Products , Cross Border Contract Manufacturing , Clearer Guidance , Issuing Answers , Frequently Asked Questions , Human Genetic Resource Administration , Implementing Rules , Administrative Regulations , Human Genetic Resources , International Collaboration , Electronic Data Capture System , Non Substantial Involvement , Plasma From Regulatory Scope ,